This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Go to /pro/cpd-dashboard page

This page is worth 0.05 CPD credits. CPD dashboard

Go to /account/subscription-details page

This page is worth 0.05 CPD credits. Upgrade to Pro

Schick test

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

The Schick test detects immunity to diphtheria, either acquired through previous infection or vaccination.

A small amount of diphtheria toxin in 0.2ml is injected intradermally into the left forearm. An equivalent amount of heat-inactivated toxin in 0.2ml is injected into the right forearm. The test is read at 1-4 days, the maximal reaction occurring on day 4.

Those who are Schick negative will have no skin reaction. This is due to sufficient antitoxin being present within the circulation to neutralise the toxin. A Schick negative person is immune and need not be immunised or reinforced. At worst, if they become infected, they will only suffer a mild attack.

A Schick positive test is an erythematous reaction developing at the site of the toxin injection after a day or two and persisting for seven or more days before fading. Schick positive individuals are susceptible to diphtheria.

Occasionally, a mild reaction may occur in the right arm only. This is a non-specific reaction to bacterial protein. It disappears by day 4. The individual is Schick negative.


Related pages

Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.